Prevalence and Factors Affecting the Use of Antipsychotics and Antipsychotic Polypharmacy in a Child and Adolescent Psychiatry Inpatient Service

Basit Öğe Kaydı
dc.authoridGavcar, Erdal Gorkem/0000-0002-1661-8759
dc.contributor.authorBuber, Ahmet
dc.contributor.authorGavcar, Erdal Gorkem
dc.contributor.authorBasay, Omer
dc.contributor.authorUnlu, Gulsen
dc.contributor.authorKabukcu Basay, Buerge
dc.contributor.authorSenol, Hande
dc.date.accessioned2025-01-21T16:43:45Z
dc.date.available2025-01-21T16:43:45Z
dc.date.issued2023
dc.departmentKırıkkale Üniversitesi
dc.description.abstractObjective: We aimed to examine the antipsychotics used by patients hospitalized in the child and youth inpatient service providing tertiary care to investigate whether there is a difference between admission and discharge, polypharmacy, which antipsychotics are used, and which psychotropics are used concomitant with antipsychotics.Methods: Research data were collected retrospectively from all children and adolescents hospitalized in a child and adolescent psychiatry inpatient service in a university hospital in a 4-year period (2015-2019). The sociodemographic and clinical characteristics of the patients, the antipsychotics they used at admission and discharge, the other psychotropics concomitantly used with antipsychotics, and the side effects associated with antipsychotics during hospitalization were collected from the files of the 363 patients.Results: Patients on antipsychotics increased 12.1% from hospitalization to discharge. Antipsychotic polypharmacy increased from 16.2% at admission to 30.7% at discharge. Logistic regression analysis was performed to investigate the factors affecting antipsychotic and antipsychotic polypharmacy. Self-harm, aggression/violence, and extended hospitalization were factors associated with increased antipsychotic use. Psychotic symptoms, psychotic disorder, and extended hospitalization were factors associated with an increase in antipsychotic polypharmacy.Conclusions: Understanding the factors that may cause antipsychotic use and polypharmacy in inpatient services in children and adolescents may prevent unnecessary drug use and long-term side effects that may occur due to these drugs.
dc.identifier.doi10.1089/cap.2022.0065
dc.identifier.endpage75
dc.identifier.issn1044-5463
dc.identifier.issn1557-8992
dc.identifier.issue2
dc.identifier.pmid36944095
dc.identifier.startpage69
dc.identifier.urihttps://doi.org/10.1089/cap.2022.0065
dc.identifier.urihttps://hdl.handle.net/20.500.12587/25311
dc.identifier.volume33
dc.identifier.wosWOS:000954232200004
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMary Ann Liebert, Inc
dc.relation.ispartofJournal of Child and Adolescent Psychopharmacology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241229
dc.subjectantipsychotic; polypharmacy; children; adolescent; inpatient service
dc.titlePrevalence and Factors Affecting the Use of Antipsychotics and Antipsychotic Polypharmacy in a Child and Adolescent Psychiatry Inpatient Service
dc.typeArticle

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu